Abstract:Foxp3(+) CD4(+) regulatory T (Treg) cells, recognized to be one of the most important defences of the human body against an inappropriate immune response, have recently gained attention from those outside immunology thanks to the compelling evidence for their capability to exert non-canonical immune functions in a variety of tissues in health and disease. The recent discovery of the differences between tissue-resident Treg cells and those derived from lymphoid organs is affecting the mindset of many investigators now questioning the broad applicability of observations originally based on peripheral blood/lymphoid organ cells. So far, the best characterized 'Treg flavour' comes from studies focused on their role in suppressing adipose tissue inflammation and obesity-driven insulin resistance. Adipose tissue derived Treg cells are distinct from their counterparts in lymphoid organs based on their transcriptional profile, T-cell receptor repertoire, and cytokine and chemokine receptor expression pattern. These cells are abundant in visceral adipose tissue of lean mice but their number is greatly reduced in insulin-resistant animal models of obesity. Interestingly, peroxisome-proliferator-activated receptor γ expression by visceral adipose tissue Treg cells is crucial for their accumulation, phenotype and function in the fat and surprisingly necessary for complete restoration of insulin sensitivity in obese mice by the anti-diabetic drug Pioglitazone. This review surveys recent findings relating to the unique phenotype and function of adipose tissue-resident Treg cells, speculates on the nature of their dynamics in lean and obese mouse models, and analyses their potential therapeutic application in the treatment of type 2 diabetes.

γδ T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis

γδ T cells and adipocyte IL-17RC control fat innervation and thermogenesis

Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis

IL-17 has a role in whole-body homeostasis

Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice

Accumulation of γδ T cells in visceral fat with aging promotes chronic inflammation

The intrinsic and extrinsic regulation of γδ-T17 cells through the IL-17-IL-17r axis during homeostasis (LYM2P.729)

Tissue adaptation of regulatory T cells in adipose tissue

Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity

A Unique Population: Adipose-Resident Regulatory T Cells.

Interferon-α-producing Plasmacytoid Dendritic Cells Drive the Loss of Adipose Tissue Regulatory T Cells During Obesity

Genetic models reveal origin, persistence and non-redundant functions of IL-17-producing γδ T cells.

Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors

Restriction of innate Tγδ17 cell plasticity by an AP-1 regulatory axis

Ketogenesis activates metabolically protective γδ T cells in visceral adipose tissue

Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation

Distinct iNKT Cell Populations Use IFNγ or ER Stress-Induced IL-10 to Control Adipose Tissue Homeostasis

Differential IL18 signaling via IL18 receptor and Na-Cl co-transporter discriminating thermogenesis and glucose metabolism regulation

Pleiotropic adipose Treg subsets, defined by Atf3 expression, modulate adipocyte energy expenditure and weight loss

IL-10 Signaling Remodels Adipose Chromatin Architecture to Limit Thermogenesis and Energy Expenditure

Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential